SCHEMBL18323673

SCHEMBL18323673

CCOc1cc(C(N)=O)cc2nnc(CC)n12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.43
LMNA P02545 2/20 0.39
HTT P42858 1/20 0.39
PARP10 Q53GL7 1/20 0.39
NCOA1 Q15788 1/20 0.37
NCOA3 Q9Y6Q9 1/20 0.37
BPTF Q12830 1/20 0.37
MAPK1 P28482 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
POLB P06746 3/20 0.33
KDM4E B2RXH2 2/20 0.33
MET P08581 1/20 0.32
CHEK2 O96017 1/20 0.32
MAPT P10636 2/20 0.31
ALDH1A1 P00352 2/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
TTK P33981 1/20 0.31
MAPK8 P45983 1/20 0.31
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18323621 0.85 TSHR (0.44) TSHRLMNAHTTPARP10NCOA1
SCHEMBL15907090 0.82 TSHR (0.41) TSHRLMNAHTTPARP10NCOA1
SCHEMBL18323624 0.80 POLB (0.36) TSHRLMNAHTTKMT2APOLB
SCHEMBL18323623 0.79 POLB (0.49) TSHRLMNAHTTKMT2APOLB
SCHEMBL18323691 0.77 MET (0.34) TSHRLMNAHTTNCOA1NCOA3
SCHEMBL18323665 0.77 KDM4E (0.40) HTTKMT2APOLBKDM4EMAPT
SCHEMBL18323625 0.77 POLB (0.34) TSHRPOLB
SCHEMBL18323678 0.75 CYP2C9 (0.35) TSHRPOLB
SCHEMBL18323607 0.74 KDM4E (0.41) LMNAHTTPOLBKDM4EALDH1A1
SCHEMBL18323633 0.72 BRD4 (0.38) TSHRLMNAHTTPARP10BPTF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9522910-B2 Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon Obshchestvo s ogranichennoy otvetstvennostyou “Fusion Pharma” (RU) 2016-12-20 US disclosed